Cryogenics

Introducing Our FDA Designated Breakthrough: BrainSee Enterprise Software for Prognostic Measurement after aMCI Diagnosis

Thursday, June 10, 2021 - 11:41pm

Darmiyan is pleased to announce that the company's first product BrainSee has obtained from the FDA a breakthrough designation granted for innovative medical devices.

Key Points: 
  • Darmiyan is pleased to announce that the company's first product BrainSee has obtained from the FDA a breakthrough designation granted for innovative medical devices.
  • Through the breakthrough program FDA separately discerned BrainSee offers a distinct advantage over existing interventions in addressing and assessing debilitating or life-threatening diseases.
  • Darmiyan's BrainSee enterprise software offers a prognostic measurement re: Alzheimer's disease based on brain MRI and cognitive assessments after an aMCI diagnosis, which may be especially useful as you consider the opportunity offered by the newly approved Aduhelm.
  • Darmiyan's proprietary technology using brain MRI is patented in the US; patents are pending in Europe, Japan and China.

Highview Enlasa Developing 50MW/500MWh Liquid Air Energy Storage Facility in the Atacama Region of Chile

Thursday, June 10, 2021 - 6:46pm

Highview Enlasa , the 50/50 joint venture between Highview Power , a global leader in long duration energy storage solutions, and Energa Latina S.A.-Enlasa , the largest backup power generation provider in Chile, is pleased to announce that it is developing the first liquid air long duration energy storage project in Chile.

Key Points: 
  • Highview Enlasa , the 50/50 joint venture between Highview Power , a global leader in long duration energy storage solutions, and Energa Latina S.A.-Enlasa , the largest backup power generation provider in Chile, is pleased to announce that it is developing the first liquid air long duration energy storage project in Chile.
  • By pairing solar with cryogenic energy storage, Chile can benefit from 24/7, 100% renewable energy.
  • Our liquid air energy storage technology is the optimal solution for the large scale, long duration energy storage that is needed to balance the grid, without the geographic constraints associated with other energy storage technologies.
  • Highview Powers proprietary cryogenic energy storage technology utilizes air liquefaction, in which ambient air is cooled and turned to liquid at -196 C (-320 F).

GBT Seeking to Adapt xCalibre Pattern Recognition Technology for Medical Imaging Analytics

Tuesday, June 8, 2021 - 11:00am

xCalibre imaging algorithms has the capability of processing high resolution images and videos detecting wide variety of pre-defined irregular objects.

Key Points: 
  • xCalibre imaging algorithms has the capability of processing high resolution images and videos detecting wide variety of pre-defined irregular objects.
  • Using GBTs proprietary neural network technology along with its computational geometry algorithms, GBT is seeking to adapt xCalibre to analyze post processed imaging of CT, Ultrasound, MRI and X-RAY.
  • xCalibre system makes it possible to process and analyze imaging information, identifying anomalies of interest.
  • We believe our AI technology could make it a potential intelligent assistant for medical professionals in wide variety of health fields.

Reflect Scientific Inc. Releases First Quarter 2021 Financials

Wednesday, June 2, 2021 - 1:00pm

For the three months ending March 31, 2021, Net income was $247,768, an increase of $82,173 from the three months ending March 31, 2020.

Key Points: 
  • For the three months ending March 31, 2021, Net income was $247,768, an increase of $82,173 from the three months ending March 31, 2020.
  • Change in product mix to more profitable freezers and chillers is responsible for this increase.
  • Based in Orem, Utah, Reflect Scientific develops and markets innovative, proprietary technologies in cryogenic cooling for the biotechnology, pharmaceutical, medical, and transportation markets.
  • Among Reflect Scientifics products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses.

Axonics® Receives FDA Approval Further Expanding MRI Labeling

Thursday, May 20, 2021 - 11:00am

b'Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, has received FDA approval allowing the use of detachable extremity coils for patients undergoing 1.5T and 3.0T MRI scans.\nThe FDA previously approved 1.5T and 3.0T MRI conditional labeling for using head and full-body transmit coils for the implantable components of the Axonics r-SNM\xc2\xae system.\nExtremity scans account for approximately 24% of all MRI scans performed today1.

Key Points: 
  • b'Axonics, Inc. (Nasdaq: AXNX), a global medical technology company that is developing and commercializing novel products for the treatment of bladder and bowel dysfunction, has received FDA approval allowing the use of detachable extremity coils for patients undergoing 1.5T and 3.0T MRI scans.\nThe FDA previously approved 1.5T and 3.0T MRI conditional labeling for using head and full-body transmit coils for the implantable components of the Axonics r-SNM\xc2\xae system.\nExtremity scans account for approximately 24% of all MRI scans performed today1.
  • The expanded labeling now includes extremity scans using \xe2\x80\x9cDetachable Upper and Lower Extremity Transmit/Receive Coils.\xe2\x80\x9d The expanded labeling is applicable to all previously implanted Axonics devices.\n\xe2\x80\x9cThese additional conditions provide Axonics with the widest range of FDA approved MRI conditions in sacral neuromodulation,\xe2\x80\x9d said Guangqiang Jiang, Ph.D., chief technology officer of Axonics.
  • This approval further demonstrates Axonics\xe2\x80\x99 commitment to continuous innovation for the benefit of patients and clinicians.\xe2\x80\x9d\nBased in Irvine, Calif., Axonics is a global medical technology company that is developing and commercializing novel products for patients with bladder and bowel dysfunction.
  • For more information, visit www.axonics.com .\n1 IMV Benchmark Report MR 2018.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210520005152/en/\n'

Highview Power Developing 2 GWh of Liquid Air Long Duration Energy Storage Projects in Spain

Wednesday, May 19, 2021 - 9:00am

b'Highview Power, a global leader in long duration energy storage solutions, announced today it is developing up to 2 GWh of long duration, liquid air energy storage projects across Spain for an estimated investment of around $1 billion.

Key Points: 
  • b'Highview Power, a global leader in long duration energy storage solutions, announced today it is developing up to 2 GWh of long duration, liquid air energy storage projects across Spain for an estimated investment of around $1 billion.
  • It is the only long duration energy storage solution available today that is locatable and delivers multiple gigawatt-hours of storage.
  • Grid operators are turning to long duration energy storage to help improve power generation economics, balance the grid, and increase reliability.\nHighview Power is a designer and developer of the CRYOBattery\xe2\x84\xa2, a proprietary cryogenic energy storage system that delivers reliable and cost-effective long duration energy storage to enable a 100% renewable energy future.
  • Its proprietary technology uses liquid air as the storage medium and can deliver anywhere from 20 MW/100 MWh to more than 200 MW/2 GWh of energy and has a lifespan of over 30 years.

Reflect Scientific Inc. Letter to Shareholders

Monday, May 17, 2021 - 1:00pm

b'OREM, Utah, May 17, 2021 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, announces a shareholder message from the CEO.\nA shareholder message from Kim Boyce, CEO of Reflect Scientific Inc.:\nAs mentioned in my previous press release, Reflect Scientific Inc. started developing cryogenic temperature control systems based on liquid nitrogen over ten years ago.

Key Points: 
  • b'OREM, Utah, May 17, 2021 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (Symbol: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, announces a shareholder message from the CEO.\nA shareholder message from Kim Boyce, CEO of Reflect Scientific Inc.:\nAs mentioned in my previous press release, Reflect Scientific Inc. started developing cryogenic temperature control systems based on liquid nitrogen over ten years ago.
  • The Company continues to be debt-free.\nOn March 30, 2021, Reflect Scientific filed a Form 10 Registration Statement with the SEC.
  • Upon effectiveness of Form 10, Reflect will become a \xe2\x80\x98fully-reporting issuer\xe2\x80\x99 with the SEC.
  • Among Reflect Scientific\xe2\x80\x99s products are low-temperature freezers and refrigerated systems for laboratory, transportation, and computer server room uses.

Hyperfine Research Brings the Category-Defining Swoop™ Portable MR Imaging System on the Road with Demo at Your Door™

Thursday, May 13, 2021 - 3:00pm

b'Guilford, CT, May 13, 2021 (GLOBE NEWSWIRE) -- Hyperfine Research is bringing its category-defining Swoop\xe2\x84\xa2 Portable MR Imaging System on the road so that healthcare professionals can participate in hands-on demonstrations.

Key Points: 
  • b'Guilford, CT, May 13, 2021 (GLOBE NEWSWIRE) -- Hyperfine Research is bringing its category-defining Swoop\xe2\x84\xa2 Portable MR Imaging System on the road so that healthcare professionals can participate in hands-on demonstrations.
  • Swoop\xe2\x84\xa2 wheels directly to the patient\xe2\x80\x99s bedside, plugs into a standard electrical outlet, and is controlled by an Apple iPad\xc2\xae.
  • Once a Demo at Your Door\xe2\x84\xa2 truck arrives at a hospital, it takes only 30 minutes to unload Swoop\xe2\x84\xa2, wheel it inside, and begin scanning.
  • This radical new model simplifies the process of acquiring medical equipment with a flattened, direct, start-to-finish approach that streamlines evaluation, purchase, and implementation of the category-defining Swoop\xe2\x84\xa2 Portable MR Imaging System.\nHyperfine\xe2\x80\x99s Swoop\xe2\x84\xa2 Portable MR Imaging System addresses limitations of current imaging technologies and makes MRI accessible anytime, anywhere, to any patient.

RSIP Vision Launches an Advanced AI-Based Tool for Prostate MRI and Ultrasound Registration Enabling Precise Navigation in Key Procedures

Thursday, May 6, 2021 - 2:00pm

b'RSIP Vision , an experienced leader in driving innovation for medical imaging through advanced AI and computer vision solutions, announced today a new prostate MRI-to-ultrasound registration tool.

Key Points: 
  • b'RSIP Vision , an experienced leader in driving innovation for medical imaging through advanced AI and computer vision solutions, announced today a new prostate MRI-to-ultrasound registration tool.
  • This provides the surgeon accurate, real-time information on regions of interest inside and near the prostate, visible mainly on the MRI scan.
  • \xe2\x80\x9cBy having RSIP Vision\xe2\x80\x99s new prostate MRI fusion tool at their fingertips, surgeons can avoid damaging sensitive internal structures.
  • During these procedures, valuable MRI information is typically not available due to the complicated nature of its acquisition in real-time.

Insight Medbotics appoints new President & CEO

Thursday, April 29, 2021 - 2:56pm

b'HAMILTON, ON, April 29, 2021 /CNW/ - The Board of Directors for Insight Medbotics, a start-up founded by MDA and the Centre for Surgical Invention and Innovation (CSii), are pleased to announce the appointment of Paul Chipperton as the company\'s Chief Executive Officer & President.\nMr.

Key Points: 
  • b'HAMILTON, ON, April 29, 2021 /CNW/ - The Board of Directors for Insight Medbotics, a start-up founded by MDA and the Centre for Surgical Invention and Innovation (CSii), are pleased to announce the appointment of Paul Chipperton as the company\'s Chief Executive Officer & President.\nMr.
  • Chipperton will be responsible for ensuring the successful execution of existing projects, including the IGAR (Image Guided Automated Robot), the world\'s first Magnetic Resonance Imaging (MRI) guided breast cancer robot.\nMr.
  • On the CSii side, the company inherits world-leading expertise in telerobotic surgery.\n"We are excited to welcome Paul as Insight Medbotics CEO.
  • "\n- Dean Mosca, Chairman of the Board of Directors, Insight Medbotics\n'